Aileron Therapeutics Appoints Vojislav Vukovic, MD, PhD, as Chief Medical Officer

Aileron Therapeutics Announces Clinical Trial Collaboration with Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Aileron Therapeutics to Report Third Quarter 2018 Financial Results on November 7, 2018

Aileron Announces Poster Presentations at Two Scientific Conferences in November

Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer

Aileron Therapeutics Reports Second Quarter 2018 Financial Results

Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference

Aileron Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018

Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute